# SpyGlass Versus ESWL for Large Common Bile Duct Stones

> **NCT05186350** · NA · COMPLETED · sponsor: **First People's Hospital of Hangzhou** · enrollment: 65 (actual)

## Conditions studied

- Choledocholithiasis
- Common Bile Duct Calculi

## Interventions

- **PROCEDURE:** ERCP+ SpyGlass
- **PROCEDURE:** ESWL+ ERCP

## Key facts

- **NCT ID:** NCT05186350
- **Lead sponsor:** First People's Hospital of Hangzhou
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-01-25
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05186350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05186350, "SpyGlass Versus ESWL for Large Common Bile Duct Stones". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05186350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*